Research
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy
-
* Corresponding author: Andrea Savarino andrea.savarino@iss.it
- † Equal contributors
Retrovirology 2010, 7:21 doi:10.1186/1742-4690-7-21
ERRATA CORRIGE
Andrea Savarino (2010-03-29 13:24) ISS
I am sorry I noticed the following errors in the published version of the manuscript:
Additional file 1: Please erase from caption: “the highly conserved catalytic residues D64, D116 and E152 (presented in yellow) and”.
Abstract: “Tenofovir disoproxil fumarate” should read, simply, "tenofovir".
Background, fourth paragraph: Again, please do not consider “disoproxil fumarate”.
Caption of Figure 2: Sixth line: Please do not consider “pro-drug”. Seventh line:“Tenofovir disoproxil fumarate” should read, simply, "tenofovir".
Methods section "Nonhuman primate studies": “50 mg/kg/BID or 100 mg/kg/BID” Please do not consider “/kg/” thus it should read as: “50 mg BID or 100 mg BID”.
Andrea Savarino, M.D.
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità,
Viale Regina Elena, 299, 00161, Rome, Italy.
andrea.savarino@iss.it
Competing interests
We have no competing interests.
top